Linagliptin Impurity 17 - Solicitar cotización

Linagliptin Impurity 17 is chemically 8-((R)-3-aminopiperidin-1-yl)-1-((4-(3-(2-((8-((S)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)quinazolin-4-yl)propyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione. Linagliptin Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Linagliptin Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linagliptin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.